RxDoctor Payments DataLook up a doctor →

Stanley Corley, MD

Family Medicine · Oklahoma City, OKNPI 1043247703

Payments from drug & device makers

$16,453in general payments, 2019–2025

Across 1,168 payments — averaging $14.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$2K
  • Novo Nordisk$1K
  • AstraZeneca$1K
  • GSK$1K
  • Amgen$995
  • plus $9K from 51 others

What the payments were for

  • Food & beverage$16,35099%
  • Education$1021%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)141$1,604
Pfizer130$1,521
Novo Nordisk129$1,430
AstraZeneca38$1,169
GSK87$1,028
Amgen(2 entities)59$995
Lilly USA, LLC63$909
Boehringer Ingelheim51$734
Abbott42$704
Bayer46$673
Amarin Pharma, Inc.50$648
Astellas Pharma US Inc38$623
Merck49$524
Takeda Pharmaceuticals U.S.A., Inc.25$396
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC24$340
Corium, LLC14$283
Axsome Therapeutics, Inc.11$279
Johnson & Johnson19$254
Idorsia Pharmaceuticals US Inc9$158
Genentech USA, Inc.9$144
Shire North American Group Inc9$137
Esperion Therapeutics, Inc.10$135
Sumitomo Pharma America, Inc.7$129
Sanofi-aventis U.S. LLC8$108
Antares Pharma, Inc.7$107
Ironwood Pharmaceuticals, Inc7$100
Jazz Pharmaceuticals Inc.6$89
Upsher-smith Laboratories LLC5$89
Novartis6$84
Exact Sciences5$82
Eisai Inc.5$79
Ironshore Pharmaceuticals Inc.4$74
Biohaven Pharmaceutical Holding Company Ltd.4$69
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$65
Kowa Pharmaceuticals America, Inc.5$64
Adlon Therapeutics L.p.4$61
Biohaven Pharmaceuticals, Inc.3$53
Aytu Biopharma, Inc.4$48
Phathom Pharmaceuticals, Inc.5$41
Almatica Pharma LLC3$38
Tris Pharma Inc2$36
Sanofi Pasteur Inc.2$33
Radius Health, Inc.1$31
Halozyme Inc2$29
IBSA Pharma Inc.2$28
Scilex Pharmaceuticals Inc.2$27
Dexcom, Inc.2$26
Xeris Pharmaceuticals, Inc.1$24
Medtronic1$23
Alnylam Pharmaceuticals Inc.2$23
Inspire Medical Systems, Inc.1$22
Lundbeck LLC1$22
Ardelyx, Inc.1$18
Supernus Pharmaceuticals, Inc.1$13
Teva Pharmaceuticals USA, Inc.1$12
Nalpropion Pharmaceuticals LLC1$11
Dynavax Technologies Corporation1$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,453 in reported general payments places this provider in the 95th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$170,502
Medicare patients
445
Services billed
5,518

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin100$120,714
EliquisApixaban47$53,365
OzempicSemaglutide26$43,954
RybelsusSemaglutide22$27,178
TrulicityDulaglutide13$22,348
MounjaroTirzepatide17$21,456
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$16,983
FarxigaDapagliflozin Propanediol19$16,122
MyrbetriqMirabegron23$14,455
JanumetSitagliptin Phos/Metformin Hcl11$6,203
Atorvastatin Calcium389$4,942
Arnuity ElliptaFluticasone Furoate11$3,555
Levothyroxine Sodium279$3,221
Gabapentin113$2,711
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$2,632

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$734$120,714100 claims
Novo NordiskOzempic, Rybelsus$1,430$71,13248 claims
PfizerEliquis$1,521$53,36547 claims
Lilly USA, LLCTrulicity, Mounjaro$909$43,80330 claims
GSKTrelegy Ellipta, Arnuity Ellipta$1,028$20,53825 claims
AstraZenecaFarxiga$1,169$16,12219 claims
Astellas Pharma US IncMyrbetriq$623$14,45523 claims
MerckJanumet$524$6,20311 claims
AbbVieSynthroid$1,604$1,30017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →